KYTHERA Biopharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference

By GlobeNewswire,  February 28, 2014, 04:33:00 PM EDT


CALABASAS, Calif., Feb. 28, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Cowen and Company 34th Annual Health Care Conference in Boston, MA.

Event: Cowen and Company 34th Annual Health Care Conference
Date: Tuesday, March 4, 2014
Time: 8:40 a.m. ET

A live webcast will be available under the Investors section of the Company's website at www.kytherabiopharma.com. The presentation will be archived on the website and will be available for at least 14 days.

About KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA's product candidate, ATX-101, is currently in late stage clinical trials for the reduction of submental fat, which commonly presents as a double chin, and is a potential first-in-class submental contouring injectable drug. KYTHERA also maintains an active research interest in hair and fat biology, pigmentation modulation and facial contouring.

CONTACT: Investor Contact:
         Heather Rowe
         Associate Director, Investor Relations
         Tel: (818) 587-4559
         hrowe@kytherabiopharma.com

Source: KYTHERA Biopharmaceuticals, Inc.

This article appears in: News Headlines

Referenced Stocks: KYTH


Latest News Video





Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.15 0.02 ▲ 0.12%
FB $ 58.94 0.78 ▼ 1.31%
GE $ 26.56 0.44 ▲ 1.68%
QQQ $ 86.20 0.02 ▲ 0.02%
CSCO $ 23.21 0.18 ▲ 0.78%
MU $ 23.91 1.43 ▲ 6.36%
ZNGA $ 4.289 0.18 ▲ 4.36%
MSFT $ 40.01 0.39 ▼ 0.97%

As of 4/17/2014, 04:07 PM